Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Emanuela Bonoldi"'
Publikováno v:
Pathologica
Summary The World Health Organization’s (WHO) updated classification of head and neck tumors (2017) defined odontogenic fibroma as a rare neoplasm. In this report, we describe an unusual, typical and rare variant of a central odontogenic fibroma wi
Publikováno v:
The American Journal of dermatopathology. 43(12)
One of the most common patterns of presentations that have been described in COVID-19 patients includes the erythematous/papular/morbilliform eruptions. However, actually, the diffuse exanthems containing macules and papules were not specific to COVI
Autor:
Emanuela Bonoldi, Andrea Toniato, Joseph Scibilia, Marta Piantanida, Scarlett Valeria Bernal Ortiz, Michele Nichelatti, Eleonora Brusamolino, Chiara Gamba, Linda Borgonovo, Valentina S. Caputo, Jan Walter Schroeder, Elide A. Pastorello, Valeria Fabbri, Luca Giuseppe Balossi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7072, p 7072 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 13
International Journal of Molecular Sciences
Volume 22
Issue 13
DRESS/DiHS is a complex and potentially fatal drug reaction. Little is known about risk factors and elements that can help to identify patients with a severe reaction early. The aim of the study was to investigate those factors favoring the disease a
Autor:
Andrea Lauterio, Maria Teresa Pugliano, Luciano De Carlis, Riccardo De Carlis, Emanuela Bonoldi, Giovanni Grillo, Ivan Vella
Publikováno v:
Clinical transplantationREFERENCES. 35(8)
Publikováno v:
The American Journal of Dermatopathology. 43:e13-e15
We report the case of a 63-year-old white man who, 3 days after stent removal of endoscopic drainage of pancreatic cysts, developed a penile necrosis due to purpura fulminans (PF) that has been misdiagnosed as Fournier's gangrene. Penile necrosis was
Publikováno v:
Virchows Archiv
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
Autor:
Caterina Vaghi, Emanuela Bonoldi, Emanuele Valtorta, Federica Tosi, Silvia Marsoni, Erika Martinelli, Valter Torri, Alberto Bardelli, Patrizia Racca, Alessio Amatu, Andrea Sartore-Bianchi, Sara Lonardi, Silvia Ghezzi, Giovanna Marrapese, Salvatore Siena, Francesco Leone, Luca Porcu, Vittorina Zagonel, Fortunato Ciardiello, Livio Trusolino, Cosimo Martino, Elisabetta Fenocchio, Beatrice Borelli, Francesca Bergamo
Publikováno v:
The Oncologist
BackgroundHER2 amplification is detected in 3% of patients with colorectal cancer (CRC), making tumors in the metastatic setting vulnerable to double pharmacological HER2 blockade. Preclinical findings show that it also might impair response to anti-
Autor:
Andrea Cassingena, Francesco Rizzetto, Andrea Sartore-Bianchi, Salvatore Siena, Maria Costanza Aquilano, Emanuela Bonoldi, Alessio Amatu, Federica Tosi, Alberto Bardelli, Gianluca Mauri, Silvia Marsoni, Pamela Arcella, Kristi Buzo, Erika Durinikova, Sabrina Arena
Publikováno v:
JCO Precision Oncology
The definition of oligometastatic colorectal cancer (CRC) identifies a peculiar subpopulation of patients characterized by a limited metastatic spread of disease.1 Oligometastatic disease is defined as the involvement of up to two or occasionally thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4380c96d042f81f9704667692a4d36b9
http://hdl.handle.net/2318/1796060
http://hdl.handle.net/2318/1796060
Autor:
Enrico Ammirati, Manlio Cipriani, Silvio Veronese, Maurizio Bottiroli, Cristina Giannattasio, Fabrizio Oliva, Emanuela Bonoldi, Marisa Varrenti, Andrea Garascia, Alice Nava, Paolo G. Camici, Carlo Federico Perno, Diana Fanti, Giacomo Veronese, Patrizia Pedrotti, Maria Frigerio, Manuela A. Bramerio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e80e607f13c36e44ab5c8215c9672c4
http://hdl.handle.net/10281/316146
http://hdl.handle.net/10281/316146
Autor:
Giovanni Cappello, Francesca Bergamo, Angelo Vanzulli, Livio Trusolino, Emanuela Bonoldi, Andrea Sartore-Bianchi, Anna Sapino, Katia Bencardino, Salvatore Siena, Sara Lonardi, Cosimo Martino, Francesco Leone, Federica Tosi, Elisabetta Fenocchio, Fortunato Ciardiello, Alberto Bardelli, Silvia Ghezzi, Vittorina Zagonel, Elena Grassi, Alessio Amatu, Silvia Marsoni, Valter Torri, Andrea Ardizzoni, Daniele Regge, Emanuele Valtorta
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
ESMO Open
ESMO Open
open 25 no Background HER2 is a therapeutic target for metastatic colorectal cancer (mCRC), as demonstrated in the pivotal HERACLES-A (HER2 Amplification for Colo-rectaL cancer Enhanced Stratification) trial with trastuzumab and lapatinib. The aim of